Institute of Biochemistry, Center for Preventive Doping Research, German Sport University Cologne, Cologne, Germany.
Anal Bioanal Chem. 2012 May;403(5):1279-89. doi: 10.1007/s00216-011-5655-2. Epub 2012 Jan 10.
In the present study, a new type of mass spectrometer combining a quadrupole mass filter, a higher collision dissociation (HCD) cell and an Orbitrap detector, was evaluated for the analysis of dried blood spots (DBS) in doping controls. DBS analysis is characterized by the necessity to detect prohibited compounds in sub-nanogram-per-milliliter levels with high identification capacity. After extraction of DBS with an organic solvent and liquid chromatographic separation (using a regular C18-RP-analytical UHPLC-column) of target analytes, mass spectrometry is performed with a high-resolution full scan in positive and negative mode by means of electrospray ionisation. Single-product ion mass spectra are acquired using the data-dependent analysis mode (employing an inclusion list) for previously selected precursors of known prohibited compounds with fixed retention time ranges. Besides, a sensitive screening in a targeted approach, non-targeted analysis for retrospective data evaluation is thus possible. The chosen experimental design enables the determination of various drugs from different classes with one generic sample preparation which is shown for 26 selected model compounds (Δ(9)-tetrahydrocannabinol (THC), tetrahydrocannabinol-9-carboxylic acid (THC-COOH), methylhexaneamine, methylphenidate, cocaine, nikethamide, 3,4-methylenedioxyamphetamine, N-methyl-3,4-methylenedioxyamphetamine, strychnine, mesocarb, salbutamol, formoterol, clenbuterol, metandienone, stanozolol, bisoprolol, propranolol, metoprolol, anastrazole, clomiphene, exemestane, dexamethasone, budesonide, selective androgen receptor modulator (SARM) S4 (andarine), SARM S1, hydrochlorothiazide). Generally, only qualitative result interpretation was focussed upon, but for target analytes with deuterium-labelled internal standards (salbutamol, clenbuterol, cocaine, dexamethasone, THC-COOH and THC) quantitative analysis was also possible. Especially the most challenging analytes, THC and its carboxy metabolite, were detected in DBS at relevant concentrations (<0.5 ng/mL) using targeted HCD experiments. The method was validated for the parameters: specificity, linearity (0-20 ng/mL), precision (<25%), recovery (mean 60%), limit of detection/quantification, ion suppression, stability and accuracy (80-120%). Six isotope-labelled analogues used as internal standards facilitate a quantitative result interpretation which is of utmost importance especially for in-competition drug sports testing.
在本研究中,评估了一种将四极杆质量过滤器、更高的碰撞解离(HCD)单元和轨道阱检测器相结合的新型质谱仪,用于兴奋剂控制中的干血斑(DBS)分析。DBS 分析的特点是需要以高识别能力检测亚纳克/毫升水平的禁用化合物。在用有机溶剂提取 DBS 并通过液相色谱分离(使用常规 C18-RP 分析 UHPLC 柱)目标分析物后,通过电喷雾电离以正、负模式进行高分辨率全扫描。使用数据依赖性分析模式(使用包含列表)获取单产物离子质谱,对具有固定保留时间范围的已知禁用化合物的先前选择的前体进行分析。此外,还可以进行敏感的靶向筛选,用于回溯数据分析的非靶向分析。所选择的实验设计可实现一种通用的样品制备,用于测定不同类别的各种药物,这在 26 种选定的模型化合物中得到了证明(Δ(9)-四氢大麻酚(THC)、四氢大麻酚-9-羧酸(THC-COOH)、甲基己胺、哌甲酯、可卡因、尼可刹米、3,4-亚甲二氧基苯丙胺、N-甲基-3,4-亚甲二氧基苯丙胺、士的宁、美索卡、沙丁胺醇、福莫特罗、克仑特罗、美雄酮、司坦唑醇、比索洛尔、普萘洛尔、美托洛尔、阿那曲唑、氯米芬、依西美坦、地塞米松、布地奈德、选择性雄激素受体调节剂(SARM)S4(安非他酮)、SARM S1、氢氯噻嗪)。通常,仅专注于定性结果解释,但对于具有氘标记内标物的目标分析物(沙丁胺醇、克仑特罗、可卡因、地塞米松、THC-COOH 和 THC)也可以进行定量分析。特别是使用靶向 HCD 实验,在相关浓度(<0.5ng/mL)下检测到最具挑战性的分析物,即 THC 和其羧基代谢物。该方法针对以下参数进行了验证:特异性、线性(0-20ng/mL)、精密度(<25%)、回收率(平均 60%)、检测限/定量限、离子抑制、稳定性和准确度(80-120%)。使用作为内标物的六种同位素标记类似物有助于进行定量结果解释,这对于比赛中的药物运动测试尤其重要。